Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
MIMEDX to Participate in Upcoming Investor Conferences
-
CERo Therapeutics, Inc. Provides Corporate Update for Shareholders
-
Osmol Therapeutics Appoints Christopher S. Eklund to its Board of Directors
-
Aktsiaselts Infortar acquired an additional shareholding in AS Tallink Grupp
-
AS Tallink Grupp: Managers’ Transactions
-
MegaWatt Metals Provides Overview of Uranium Sector & Domestic Demand and Mining Opportunities
-
Notice Regarding Uab „orkela“ Financial Statements for 3-Month Period Ended 31 March 2024
-
ROCKWOOL A/S – transactions in connection with share buy-back programme
-
Solid Biosciences Provides First Quarter 2024 Business Update and Financial Results
-
Koryx Copper Intersects 338.61 Meters At 0.38% Cu Eq Including 230.61 Meters At 0.45% Cu Eq and Multiple 2 Meters Intersections Over 1.00% Cu Eq
-
Microbix Reports Strong Results for Q2 Fiscal 2024
-
Share repurchase programme
-
Predicting the Next Bullish Coins of 2024, Toobit Experts Weigh In
-
Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents
-
Probe Gold Advances Environmental Permitting for Novador Project: Submits Detailed Project Description
-
FameEX Leads the Way in Simplifying Crypto Trading Amidst Market Expansion
-
PDD Holdings to Report First Quarter 2024 Unaudited Financial Results on May 22, 2024
-
Gildan Activewear Board of Directors Issues Letter to Shareholders
-
Prime Drink Group Corp. Enters Into Definitive Agreement to Acquire Triani Canada Inc.
-
Nayax Reports First Quarter 2024 Financial Results
-
Aspira Women’s Health Reports First Quarter 2024 Financial Results
-
Enable Injections and Serina Therapeutics Announce Agreement to Develop SER-252 in Combination with enFuse® for Advanced Parkinson’s Disease
-
M&T Bank Expands Use of nCino with Adoption of Continuous Credit Monitoring Solution Powered by Rich Data Co’s Explainable AI Platform
-
AppTech Payments Corp. Reports Strong Start to 2024 with Positive First Quarter Financial Results and Strategic Business Advances
-
Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2024
-
CORRECTION – Dragonfly Energy Reports First Quarter 2024 Financial and Operational Results
-
DeFi Technologies Subsidiary Valour Inc. Launches World's First Yield Bearing Bitcoin (BTC) ETP in Collaboration with Core Foundation, Offering Investors Exposure to Bitcoin with a 5.65% Yield
-
Lilium Welcomes KfW Due Diligence Undertaking
-
Base Carbon Reports First-Quarter 2024 Operating and Financial Results
-
Flow Capital Announces a US$4.0 Million Loan to Tattle
-
Verrica Pharmaceuticals Announces Amendment to Company’s Collaboration and License Agreement with Torii Pharmaceutical Co. Ltd. to Fund Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for th
-
LeddarTech Reports F2Q24 Results
-
Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress
-
Intermap Expands Space Communications Infrastructure Contract
-
M&T Bank Expands Use of nCino with Adoption of Continuous Credit Monitoring Solution Powered by Rich Data Co’s Explainable AI Platform
-
Bread Financial™ Provides Performance Update for April 2024
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
VEON Publishes Annual Corporate Governance Report for Financial Year 2023
-
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
-
CLIF BAR Re-Launches “Loop the Lincoln” to Advance Organic Food and Farming Initiatives
-
Result of AGM
-
ADC Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
-
New University of Toronto Scarborough student residence becomes largest Passive House certified building in Canada
-
HSBC Continental Europe: Pre Stabilisation Notice
-
Unicycive Therapeutics Presents Bioequivalence Data on Oxylanthanum Carbonate (OLC) at the National Kidney Foundation Spring Clinical Meeting
-
ATHA Energy Provides Update on 2024 Exploration Program
-
Guardian Capital Announces May 2024 Cash Distributions for Guardian Capital ETFs
-
BurgerFi Reports First Quarter 2024 Results
-
Edible Garden Reports Significant 27.6% Year-Over-Year Revenue Growth for First Quarter of 2024
-
Olema Oncology Announces Promising New Data for Palazestrant in Combination with Ribociclib Presented at the 2024 ESMO Breast Cancer Congress

